BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 16704199)

  • 21. Site-directed enzymatic PEGylation of the human granulocyte colony-stimulating factor.
    Maullu C; Raimondo D; Caboi F; Giorgetti A; Sergi M; Valentini M; Tonon G; Tramontano A
    FEBS J; 2009 Nov; 276(22):6741-50. PubMed ID: 19843182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel polyethylene glycol derivative suitable for the preparation of mono-PEGylated protein.
    Yun Q; Chen T; Zhang G; Bi J; Ma G; Su Z
    Biotechnol Lett; 2005 Feb; 27(3):213-7. PubMed ID: 15717132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain.
    Manjula BN; Tsai A; Upadhya R; Perumalsamy K; Smith PK; Malavalli A; Vandegriff K; Winslow RM; Intaglietta M; Prabhakaran M; Friedman JM; Acharya AS
    Bioconjug Chem; 2003; 14(2):464-72. PubMed ID: 12643758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering.
    Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA
    Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubility and binding properties of PEGylated lysozyme derivatives with increasing molecular weight on hydrophobic-interaction chromatographic resins.
    Müller E; Josic D; Schröder T; Moosmann A
    J Chromatogr A; 2010 Jul; 1217(28):4696-703. PubMed ID: 20570270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical and enzymatic site specific PEGylation of hGH.
    da Silva Freitas D; Mero A; Pasut G
    Bioconjug Chem; 2013 Mar; 24(3):456-63. PubMed ID: 23432141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation.
    Leong SR; DeForge L; Presta L; Gonzalez T; Fan A; Reichert M; Chuntharapai A; Kim KJ; Tumas DB; Lee WP; Gribling P; Snedecor B; Chen H; Hsei V; Schoenhoff M; Hale V; Deveney J; Koumenis I; Shahrokh Z; McKay P; Galan W; Wagner B; Narindray D; Hébert C; Zapata G
    Cytokine; 2001 Nov; 16(3):106-19. PubMed ID: 11741351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Betaseron.
    Lin L
    Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of PEGylation and refolding for renaturation of recombinant proteins from insoluble aggregates produced in bacteria--application to a single-chain Fv fragment.
    Kumagai I; Asano R; Nakanishi T; Hashikami K; Tanaka S; Badran A; Sanada H; Umetsu M
    J Biosci Bioeng; 2010 May; 109(5):447-52. PubMed ID: 20347766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin.
    Nie Y; Zhang X; Wang X; Chen J
    Bioconjug Chem; 2006; 17(4):995-9. PubMed ID: 16848407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary electrophoretic separation of high-molecular-weight poly(ethylene glycol)-modified proteins.
    Na DH; Park EJ; Jo YW; Lee KC
    Anal Biochem; 2008 Feb; 373(2):207-12. PubMed ID: 17888863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
    Pepinsky RB; Lee WC; Cornebise M; Gill A; Wortham K; Chen LL; Leone DR; Giza K; Dolinski BM; Perper S; Nickerson-Nutter C; Lepage D; Chakraborty A; Whalley ET; Petter RC; Adams SP; Lobb RR; Scott DM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):742-50. PubMed ID: 15485895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.
    Wang YJ; Hao SJ; Liu YD; Hu T; Zhang GF; Zhang X; Qi QS; Ma GH; Su ZG
    J Control Release; 2010 Aug; 145(3):306-13. PubMed ID: 20427020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
    Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, modeling, and expression of erythropoietin cysteine analogs in Pichia pastoris: improvement of mean residence times and in vivo activities through cysteine-specific PEGylation.
    Maleki A; Madadkar-Sobhani A; Roohvand F; Najafabadi AR; Shafiee A; Khanahmad H; Cohan RA; Namvar N; Tajerzadeh H
    Eur J Pharm Biopharm; 2012 Apr; 80(3):499-507. PubMed ID: 22068050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEGylated murine Granulocyte-macrophage colony-stimulating factor: production, purification, and characterization.
    Sainathan SK; Tu L; Bishnupuri KS; Han M; Li A; Newberry RD; McDonald KG; Crimmins DL; Houchen C; Anant S; Dieckgraefe BK
    Protein Expr Purif; 2005 Dec; 44(2):94-103. PubMed ID: 16213750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Site-specific PEGylation at histidine tags.
    Cong Y; Pawlisz E; Bryant P; Balan S; Laurine E; Tommasi R; Singh R; Dubey S; Peciak K; Bird M; Sivasankar A; Swierkosz J; Muroni M; Heidelberger S; Farys M; Khayrzad F; Edwards J; Badescu G; Hodgson I; Heise C; Somavarapu S; Liddell J; Powell K; Zloh M; Choi JW; Godwin A; Brocchini S
    Bioconjug Chem; 2012 Feb; 23(2):248-63. PubMed ID: 22243664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.